
Mobile App Boosts HIV Treatment Adherence in Trial
A randomised trial found a smartphone intervention lowered detectable HIV viral load among sexual minority men who use stimulants.
This section covers substance abuse and addiction in the United States — opioid and other drug overdoses, treatment options, recovery programs and the public health and policy dimensions of addiction. Reporting is distinct from drug crime coverage and focuses on the health dimensions of the subject.

A randomised trial found a smartphone intervention lowered detectable HIV viral load among sexual minority men who use stimulants.
November 7, 2026
Perry's Addiction Advice Resurfaces, Sparks DebateA 2022 video of the late actor describing his recovery advice went viral on X, prompting arguments over whether addiction is a disease or a matter of personal responsibility.
November 7, 2026
Flyysoulja Says Psychosis, Not Overdose, Led to HospitalThe rapper said doctors diagnosed a drug-induced psychotic episode after he was rushed to a Miami trauma unit.
November 7, 2026
Alkermes Presents Data at NEI Fall CongressThe company will share research on its psychiatry and sleep portfolios at the November 5 to 8 meeting in Colorado Springs.
November 6, 2026
Lil Jon Recalls Final Call With SonThe rapper shared the last phone conversation he had with his son, Nathan Smith, who died in a Georgia pond after psilocybin use.
November 6, 2026
Kudzu Supplement Cuts Binge Drinking in Small StudyA 12-week randomized trial of 120 adults with alcohol use disorder found kudzu reduced binge drinking days more than placebo.
November 6, 2026
Study Tracks Severe Alcohol Hepatitis OutcomesA real-world analysis of 1,630 U.S. adults hospitalized with severe alcohol-associated hepatitis reports survival, rehospitalization and transplant estimates.
November 5, 2026
Netflix Docuseries Tops Global TV ChartsThe One About Matthew Perry, a three-episode docuseries, debuted on Netflix with strong early viewership and critical acclaim.
November 5, 2026
Pemvidutide Alcohol Data Set for Liver MeetingAltimmune will present Phase 2 RECLAIM results for pemvidutide in adults with moderate-to-severe alcohol use disorder at AASLD The Liver Meeting 2026.
November 5, 2026
Solvonis Wins Ketamine Patent for Addiction UseThe US Patent and Trademark Office allowed claims covering ketamine at dissociative doses for behavioural addictions.
November 4, 2026
Cannabis Dominates Teen Substance Emergency VisitsA study of more than 5 million U.S. emergency visits and hospitalizations finds cannabis leads among younger people while alcohol leads among older adults.
Overdose death data and what drives it, treatment approval and availability, recovery program outcomes, state-level drug policy changes and the public health infrastructure built to address addiction are the recurring subjects in this coverage. New York, Los Angeles, Chicago, Houston and Phoenix are among the metropolitan areas where overdose rates, treatment capacity and harm reduction services receive the most sustained public health attention, and conditions in those cities anchor coverage of how the crisis is being managed at scale. The opioid epidemic has been the dominant story in this coverage area for an extended period, but stimulant use and polysubstance deaths have become increasingly prominent secondary subjects as the overdose landscape has shifted. Treatment access and the gap between need and available capacity generate a persistent structural story that runs beneath the data releases and policy announcements.